Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
1(100.0%)
1Total
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT04448301Not ApplicableCompleted

PC001- A Study to Evaluate the Usability of PointCheck

Role: lead

NCT04889937Completed

Usability, Adherence and Diagnostic Performance of PointCheck in Pediatric Population

Role: lead

NCT06323447Not Yet Recruiting

Pivotal Study to Validate a Novel System to Non-Invasively Detect Severe Neutropenia

Role: lead

NCT04448314Completed

Study to Evaluate the Usability of PointCheck

Role: lead

All 4 trials loaded